COST-EFFECTIVENESS OF ANTIMICROBIAL RESISTANCE POINT-OF-CARE TESTING FOR OPTIMISING THE TREATMENT OF GONORRHOEA

被引：0
|
作者：
Harding-Esch, Emma [1 ]
Huntington, Susie E. [1 ]
Harvey, Mike [1 ]
Broad, Claire E. [1 ]
Adams, Elisabeth J. [1 ]
Sadiq, S. Tariq [1 ]
机构：
[1] St Georges Univ London, Appl Diagnost Res & Evaluat Unit, London, England
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2017年 / 93卷
关键词：
D O I：
10.1136/sextrans-2017-053264.86
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
O15.3
引用
收藏
页码：A34 / A35
页数：2
相关论文
共 50 条
  • [1] Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics
    Harding-Esch, Emma M.
    Huntington, Susie E.
    Harvey, Michael J.
    Weston, Georgie
    Broad, Claire E.
    Adams, Elisabeth J.
    Sadiq, S. Tariq
    EUROSURVEILLANCE, 2020, 25 (43)
  • [2] Cost-effectiveness of point-of-care testing for dehydration in the pediatric ED
    Whitney, Rachel E.
    Santucci, Karen
    Hsiao, Allen
    Chen, Lei
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (08): : 1573 - 1575
  • [3] Cost-effectiveness analysis of early point-of-care lactate testing in the emergency department
    Ward, Michael J.
    Self, Wesley H.
    Singer, Adam
    Lazar, Danielle
    Pines, Jesse M.
    JOURNAL OF CRITICAL CARE, 2016, 36 : 69 - 75
  • [4] Cost-effectiveness and laboratory turnaround time using expanded point-of-care testing in the ICU
    Giuliano, KK
    Higgins, TL
    Pysznik, E
    McGee, W
    Perkins, S
    Jaciow, D
    CRITICAL CARE MEDICINE, 1999, 27 (01) : A115 - A115
  • [5] THE COST-EFFECTIVENESS OF ANTENATAL SYPHILIS SCREENING USING POINT-OF-CARE TESTING IN LATIN AMERICA
    Komakech, H.
    Muhumuza, C.
    Lamorde, M.
    Marques, E.
    Kuznik, A.
    VALUE IN HEALTH, 2014, 17 (03) : A160 - A160
  • [6] Cost-effectiveness of point-of-care testing for influenza at community pharmacy setting in Hong Kong
    Tam, Lok-pui
    You, Joyce
    PHARMACOTHERAPY, 2016, 36 (12): : E263 - E263
  • [7] The cost-effectiveness of molecular point of care testing for chlamydia, gonorrhoea and trichomonas in remote primary care health services in Australia
    Watts, C. G.
    Causer, L. M.
    Donovan, B.
    Hui, B.
    Tangey, A.
    Smith, K.
    Andrewartha, K.
    Fairley, C. K.
    Mak, D.
    Shephard, M. D.
    Ward, J.
    Kaldor, J.
    Persing, D.
    Atkinson, D.
    Anderson, D.
    Huang, R. L.
    Armstrong, P.
    Speers, D.
    Maher, L.
    Regan, D. G.
    Wand, H.
    Whiley, D.
    Marshall-Lang, R.
    Badman, S. G.
    Hengel, B.
    Gunathilake, M.
    Guy, R. J.
    Wiseman, V.
    SEXUAL HEALTH, 2024, 21 (04) : 114 - 115
  • [8] Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting
    You, Joyce H. S.
    Tam, Lok-pui
    Lee, Nelson L. S.
    PLOS ONE, 2017, 12 (07):
  • [9] Cost-effectiveness of point-of-care diagnostics for AMR: a systematic review
    Tolley, Abraham
    Bansal, Akhil
    Murerwa, Rebecca
    Dicks, James Howard
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (06) : 1248 - 1269
  • [10] Is nucleic acid amplification point-of-care testing for chlamydia and gonorrhoea cost-effective?
    Miners, Alec
    SEXUALLY TRANSMITTED INFECTIONS, 2014, 90 (02) : 82 - 82
12345